Correlation Between Tempest Therapeutics and Oncolytics Biotech
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Oncolytics Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Oncolytics Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Oncolytics Biotech, you can compare the effects of market volatilities on Tempest Therapeutics and Oncolytics Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Oncolytics Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Oncolytics Biotech.
Diversification Opportunities for Tempest Therapeutics and Oncolytics Biotech
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tempest and Oncolytics is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Oncolytics Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncolytics Biotech and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Oncolytics Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncolytics Biotech has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Oncolytics Biotech go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Oncolytics Biotech
Given the investment horizon of 90 days Tempest Therapeutics is expected to generate 1.15 times more return on investment than Oncolytics Biotech. However, Tempest Therapeutics is 1.15 times more volatile than Oncolytics Biotech. It trades about 0.02 of its potential returns per unit of risk. Oncolytics Biotech is currently generating about -0.31 per unit of risk. If you would invest 96.00 in Tempest Therapeutics on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Tempest Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tempest Therapeutics vs. Oncolytics Biotech
Performance |
| Timeline |
| Tempest Therapeutics |
| Oncolytics Biotech |
Tempest Therapeutics and Oncolytics Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and Oncolytics Biotech
The main advantage of trading using opposite Tempest Therapeutics and Oncolytics Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Oncolytics Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will offset losses from the drop in Oncolytics Biotech's long position.| Tempest Therapeutics vs. Indaptus Therapeutics | Tempest Therapeutics vs. Rezolute | Tempest Therapeutics vs. Forte Biosciences | Tempest Therapeutics vs. Sana Biotechnology |
| Oncolytics Biotech vs. Scpharmaceuticals | Oncolytics Biotech vs. Milestone Pharmaceuticals | Oncolytics Biotech vs. Seres Therapeutics | Oncolytics Biotech vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |